Orphan designation: Enzastaurin hydrochloride Treatment of Ehlers-Danlos syndrome, 24/02/2022 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 October 2024 - 10:00

Orphan designation: Enzastaurin hydrochloride Treatment of Ehlers-Danlos syndrome, 24/02/2022 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2582

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters